Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? [version 2; referees: 2 approved]

Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? [version 2; referees: 2 approved]

Stakeholders in healthcare are increasingly turning to real world evidence (RWE) to inform their decisions, alongside evidence from randomized controlled trials. RWE is generated by analysing data gathered from routine clinical practice, and can be used across the product lifecycle, providing insigh...

Full description

Bibliographic Details
Main Authors:	Sajan Khosla, Robert White, Jesús Medina, Mario Ouwens, Cathy Emmas, Tim Koder, Gary Male, Sandra Leonard
Format:	Article
Language:	English
Published:	F1000 Research Ltd 2018-08-01
Series:	F1000Research
Online Access:	https://f1000research.com/articles/7-111/v2

Similar Items

Real world evidence (RWE) – a disruptive innovation or the quiet evolution of medical evidence generation? [version 1; referees: 2 approved]
by: Sajan Khosla, et al.
Published: (2018-01-01)

Real world evidence (RWE) - Are we (RWE) ready?
by: Viraj Ramesh Suvarna
Published: (2018-01-01)

Do the disruptive business models of energy companies Solarcity, RWE and d.light fit into theoretical disruption models?
by: Gallego, Maria Belen Filgueira
Published: (2017)

RWE Framework: An Interactive Visual Tool to Support a Real-World Evidence Study Design
by: Andrew D. Xia, et al.
Published: (2019-11-01)

Developing a multi-center clinical data mart of ACEI and ARB for real-world evidence (RWE)
by: Hun-Sung Kim, et al.
Published: (2018-12-01)

Evidence against pain specificity in the dorsal posterior insula [version 1; referees: 2 approved]
by: Karen D. Davis, et al.
Published: (2015-07-01)

PhenoPlasm: a database of disruption phenotypes for malaria parasite genes [version 2; referees: 2 approved]
by: Theo Sanderson, et al.
Published: (2017-07-01)

The academic, economic and societal impacts of Open Access: an evidence-based review [version 2; referees: 4 approved, 1 approved with reservations]
by: Jonathan P. Tennant, et al.
Published: (2016-06-01)

The academic, economic and societal impacts of Open Access: an evidence-based review [version 3; referees: 3 approved, 2 approved with reservations]
by: Jonathan P. Tennant, et al.
Published: (2016-09-01)

The academic, economic and societal impacts of Open Access: an evidence-based review [version 1; referees: 2 approved, 1 approved with reservations]
by: Jonathan P. Tennant, et al.
Published: (2016-04-01)

Advances in understanding and managing bullous pemphigoid [version 1; referees: 2 approved]
by: Cathy Y. Zhao, et al.
Published: (2015-11-01)

Developing WHO guidelines: Time to formally include evidence from mathematical modelling studies [version 2; referees: 2 approved]
by: Matthias Egger, et al.
Published: (2018-02-01)

Case Report: Diffuse T wave inversions as initial electrocardiographic evidence in acute pulmonary embolism [version 2; referees: 2 approved]
by: Ogechukwu Egini, et al.
Published: (2018-09-01)

Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis [version 2; referees: 2 approved]
by: Ana C. Londoño, et al.
Published: (2017-06-01)

Behavioural evidence for self-medication in bumblebees? [version 3; referees: 3 approved]
by: David Baracchi, et al.
Published: (2015-10-01)

Reproducibility2020: Progress and priorities [version 1; referees: 2 approved]
by: Leonard P. Freedman, et al.
Published: (2017-05-01)

Automated Wormscan [version 2; referees: 2 approved, 1 approved with reservations]
by: Timothy Puckering, et al.
Published: (2017-09-01)

Lost in translation [version 2; referees: 2 approved]
by: Parashkev Nachev, et al.
Published: (2019-01-01)

PhenoPlasm: a database of disruption phenotypes for malaria parasite genes [version 1; referees: 2 approved]
by: Theo Sanderson, et al.
Published: (2017-06-01)

Podocytes [version 1; referees: 2 approved]
by: Jochen Reiser, et al.
Published: (2016-01-01)

Nephrotoxicities [version 1; referees: 2 approved]
by: Stuart L. Goldstein
Published: (2017-01-01)

Regional or general anesthesia for fast-track hip and knee replacement - what is the evidence? [version 1; referees: 2 approved]
by: Henrik Kehlet, et al.
Published: (2015-12-01)

An update around the evidence base for the lower extremity ultrasound regional block technique [version 1; referees: 2 approved]
by: Andrea Fanelli, et al.
Published: (2016-01-01)

Strong evidence that callous–unemotional traits are not related to risk-taking task performance [version 1; referees: 2 approved]
by: Luna C. M. Centifanti, et al.
Published: (2018-04-01)

I drink for my liver, Doc: emerging evidence that coffee prevents cirrhosis [version 2; referees: 3 approved]
by: Jordan J. Feld, et al.
Published: (2015-11-01)

No evidence for clonal transmission of urogenital carcinoma in California sea lions (Zalophus californianus) [version 1; referees: 2 approved]
by: Máire Ní Leathlobhair, et al.
Published: (2017-06-01)

Monitoring the compliance of the academic enterprise with the Fair Labor Standards Act [version 2; referees: 2 approved, 1 approved with reservations]
by: Adriana Bankston, et al.
Published: (2017-09-01)

Stroke rehabilitation research needs to be different to make a difference [version 1; referees: 2 approved]
by: Cathy M. Stinear
Published: (2016-06-01)

The future of metabolomics in ELIXIR [version 2; referees: 2 approved, 1 approved with reservations]
by: Merlijn van Rijswijk, et al.
Published: (2017-10-01)

Chemoprevention of cancer: current evidence and future prospects [version 1; referees: 3 approved]
by: Vassiliki Benetou, et al.
Published: (2015-09-01)

Investigation of chimeric reads using the MinION [version 2; referees: 2 approved]
by: Ruby White, et al.
Published: (2017-08-01)

Awareness, Knowledge, and Utility of RCT Data vs RWE: Results From a Survey of US Cardiologists: Real-world Evidence in Clinical Decision Making
by: Todd C Villines, et al.
Published: (2020-09-01)

Evidence synthesis and decision modelling to support complex decisions: stockpiling neuraminidase inhibitors for pandemic influenza usage [version 2; referees: 2 approved]
by: Samuel I. Watson, et al.
Published: (2017-03-01)

Conventional NK cells and ILC1 are partially ablated in the livers of Ncr1iCreTbx21fl/fl mice [version 2; referees: 2 approved]
by: Antonia O. Cuff, et al.
Published: (2017-07-01)

Evidence of disease control: a realistic concept beyond NEDA in the treatment of multiple sclerosis [version 1; referees: 2 approved]
by: Ana C. Londoño, et al.
Published: (2017-04-01)

Automated Wormscan [version 3; referees: 2 approved, 1 approved with reservations]
by: Timothy Puckering, et al.
Published: (2019-01-01)

Automated Wormscan [version 1; referees: 2 approved, 1 approved with reservations]
by: Timothy Puckering, et al.
Published: (2017-02-01)

Chikungunya: epidemiology [version 1; referees: 2 approved]
by: Lyle R. Petersen, et al.
Published: (2016-01-01)

Advances in Laryngoscopy [version 1; referees: 2 approved]
by: Michael Aziz
Published: (2015-12-01)

Ketamine for pain [version 1; referees: 2 approved]
by: Kelly Jonkman, et al.
Published: (2017-09-01)